Search results
Results from the WOW.Com Content Network
The study examined the number of times the non-medical use of certain drugs was implicated in an ED visit. The criteria for non-medical use in this study were purposefully broad, and include, for example, drug abuse, accidental or intentional overdose, or adverse reactions resulting from legitimate use of the medication. [138]
The severity and length of the withdrawal syndrome is likely determined by various factors, including rate of tapering, length of use and dosage size, and possible genetic factors. [ 25 ] [ 129 ] Those who have a prior history of withdrawing from benzodiazepines may have a sensitized or kindled central nervous system leading to worsening ...
Medication discontinuation is the ceasing of a medication treatment for a patient by either the clinician or the patient themself. [ 1 ] [ 2 ] When initiated by the clinician, it is known as deprescribing . [ 3 ]
Some packages of clonazepam were labeled with the incorrect dosage strength and National Drug Code (NDC), which is the FDA's identifier for drugs, according to Endo, Inc., the drug's manufacturer.
Clonazepam, an anxiety drug, is being voluntarily recalled for the potential to cause a “life-threatening” event. ... Distributors and retailers should stop dispensing the recalled product. It ...
Additional packages of clonazepam, a prescription medication used to treat seizures and anxiety, mislabeled with the incorrect strength have been added to a voluntary recall, according to the U.S ...
Tablets of the drug clonazepam, the generic name for Klonopin, which is used to treat epilepsy, panic disorder and muscle spasms, have been recalled for incorrect labeling that could inadvertently ...
It is a Schedule I controlled substance in the United States and is not FDA approved for human consumption. Virginia state law has declared all of the following related medications are Schedule I: clonazolam, etizolam, flualprazolam, flubromazolam, and flubromazepam. [10] Minnesota declared clonazolam a Schedule I drug in August 2020. [citation ...